Abstract

Study design:Case study
Purpose:Recognition of drugs that have the potential to incite angle closure is paramount in identifying patients at risk for AACG as well as preventing and managing this complication
Method:A 62 year old female patient diagnosed with depression was referred from Psychiatry for pain, and redness in LE.Distant vision was 6/18 in RE and 6/60 in LE.Corneal epithelial edema with circumcorneal congestion was noted.IOP was 28 and 64 mmHg on Goldmann’s applanation tonometry.Patient was on Desvenlafaxine and Clonazepam for depression.The clinical findings and drug history lead to a strong suspension of drug induced acute angle closure attack.Results:After withdrawing Desvenlafaxine and starting topical antiglaucoma medication with oral acetazolamide and IV mannitol IOP was reduced to 12 in BE the next day.Patient was clinically and symptomatically better.
Conclusion:Clinicians should review medications in patients presenting with symptoms of acute angle closure glaucoma